Pavletta S Shestakova's Profile

Role	Title	Level	Year	L/R
🐜	Anticancer Potencies of Pt(II) - and Pd(II)-linked M2L4 Coordination Capsules with Improved Selectivity. 7 auth. A. Ahmedova, D. Momekova, Masahiro Yamashina, Pavletta S Shestakova, G. Momekov, M. Akita, ... M. Yoshizawa	5	2016	5 🐜
🐜	Star-shaped nano-conjugates of cisplatin with high drug payload. 7 auth. A. Kowalczuk, E. Stoyanova, V. Mitova, Pavletta S Shestakova, G. Momekov, D. Momekova, ... N. Koseva	5	2011	5 🐜
🐢	Silver- and sulfadiazine-loaded nanostructured silica materials as potential replacement of silver sulfadiazine. Á. Szegedi, M. Popova, K. Yoncheva, J. Makk, J. Mihály, Pavletta S Shestakova	5	2014	5 🐢
🐜	Zr-modified hierarchical mordenite as heterogeneous catalyst for glycerol esterification 9 auth. M. Popova, H. Lazarova, Y. Kalvachev, T. Todorova, Á. Szegedi, Pavletta S Shestakova, ... G. Mali, V. Dasireddy, B. Likozar	5	2017	5 🐜
🐬	Multinuclear diffusion NMR spectroscopy and DFT modeling: a powerful combination for unraveling the mechanism of phosphoester bond hydrolysis catalyzed by metal-substituted polyoxometalates. T. Luong, Pavletta S Shestakova, T. Mihaylov, Gregory Absillis, K. Pierloot, T. Parac‐Vogt	5	2015	5 🐬
🐜	Efficient solid acid catalysts based on sulfated tin oxides for liquid phase esterification of levulinic acid with ethanol 11 auth. M. Popova, Pavletta S Shestakova, H. Lazarova, M. Dimitrov, D. Kovacheva, Á. Szegedi, ... G. Mali, V. Dasireddy, B. Likozar, N. Wilde, R. Gläser	5	2018	5 🐜
🐢	New method for preparation of delivery systems of poorly soluble drugs on the basis of functionalized mesoporous MCM-41 nanoparticles 8 auth. M. Popova, A. Szegedi, K. Yoncheva, S. Konstantinov, G. Petrova, H. Aleksandrov, ... G. Vayssilov, Pavletta S Shestakova	5	2014	5 🐢
🐜	M2L4 coordination capsules with tunable anticancer activity upon guest encapsulation. 10 auth. A. Ahmedova, Rositsa Mihaylova, D. Momekova, Pavletta S Shestakova, S. Stoykova, Joana Zaharieva, ... Masahiro Yamashina, G. Momekov, M. Akita, M. Yoshizawa	5	2016	5 🐜